Kurzübersicht für Cytoskeleton-Associated Protein 4 (CKAP4) (Middle Region) Peptid (ABIN975006)
Target
CKAP4
(Cytoskeleton-Associated Protein 4 (CKAP4))
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Protein Region
Middle Region
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-CKAP4 antibody (Catalog #: ARP46790_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
CKAP4
(Cytoskeleton-Associated Protein 4 (CKAP4))
Hintergrund
CKAP4/p63 is a substrate of DHHC2, a putative tumor suppressor. CK MNF116 and p63 were useful in identifying squamous cell carcinomas with single cell infiltration. Those results suggested a role of CKAP4/p63 in tumor.
Alias Symbols: CLIMP-63, ERGIC-63, MGC99554, p63
Protein Interaction Partner: ASCC2,PLAT,ASCC2,USP50